Latest LEO Pharma News & Updates

See the latest news and media coverage for LEO Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
LEO Pharma

Medical dermatology pharmaceutical company

leo-pharma.com
Headquarters
Ballerup, Denmark
Founded year
1908
Company type
Private company
Number of employees
1,000–6,000

Last updated

Latest news about LEO Pharma

In short: LEO Pharma achieved robust 9% revenue growth in Q1 2026, advanced its IPO preparations, and expanded its portfolio through the acquisition of Replay.

Company announcements

LEO Pharma

LEO Pharma launches LOQTORZI in Denmark

LOQTORZI is combined with chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer. Clinical data show improved survival.

LEO Pharma

LEO Pharma reports Q1 2026 revenue growth

It achieves 9% CER growth, improved profitability, and acquired Replay, while advancing Anzupgo® and gaining Enstilar® approval in China.

Unlock all announcements with a

Media coverage

Børsen

Other products must carry the load

Launches its own copy In collaboration with Prasco Laboratories, Leo Pharma launches its own copy version of the drug Dovonex to gain a share of the copy market, while...

Børsen

Leo Pharma upgrades

Growth and underlying earnings show good signs, but past sins mean that equity is again being eroded this year...

Unlock all articles with a

Never miss news about LEO Pharma

Track LEO Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.